Clinical Trials Directory

Trials / Completed

CompletedNCT04257903

Different Treatment Modalities for Myofascial Pain

Effectiveness of Different Treatment Methods in Patients With Myofascial Pain Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Trakya University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers

Summary

Myofascial pain dysfunction syndrome (MPDS) is the most common reason for pain and limited function of the masticatory system. The low-level laser therapy (LLLT) and occlusal splint therapy (OST) are therapeutic options for MPDS. This study aims to evaluate the effect of LLLT and OST on pain relief and mandibular movement improvement in patients with myofascial pain.

Detailed description

Myofascial pain dysfunction syndrome in the masticatory muscles is the most common temporomandibular disorder. Patients suffer from pain and muscle tenderness and may present with or without restricted mouth opening. The etiology of myofascial pain dysfunction syndrome is multifactorial including psychological factors, occlusion imbalance, and parafunctional habits. Treatments for myofascial pain dysfunction syndrome include education, self-care, physical therapy, use of intra-oral appliances, short-term pharmacotherapy, behavioral therapy, and relaxation techniques. Temporomandibular disorder is most often treated using occlusal splints safely to reduce temporomandibular joint load, and subsequently, clinical symptoms, as a reversible therapy. Occlusal splints need to be used for at least three months to eliminate temporomandibular disorders. One of physical therapy is laser treatment. Laser treatment on tissues provides a clinical effect called biostimulation, where the basic mechanism occurs at the molecular level. The low-level laser has non-invasive and inoffensive characteristics at appropriate parameters.

Conditions

Timeline

Start date
2019-04-01
Primary completion
2019-04-01
Completion
2019-04-01
First posted
2020-02-06
Last updated
2020-02-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04257903. Inclusion in this directory is not an endorsement.